Cite
HARVARD Citation
Herrera, C. et al. (2021). Pharmacokinetic/pharmacodynamic investigation of raltegravir with or without lamivudine in the context of HIV-1 pre-exposure prophylaxis (PrEP). Journal of antimicrobial chemotherapy. pp. 2129-2136. [Online].